You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 54 No. 8, August 1997 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Fluoxetine in Depressed Alcoholics

A Double-blind, Placebo-Controlled Trial

Jack R. Cornelius, MD, MPH; Ihsan M. Salloum, MD, MPH; Joan G. Ehler, MD; Patricia J. Jarrett, MD, PhD; Marie D. Cornelius, PhD; James M. Perel, PhD; Michael E. Thase, MD; Ann Black, MS

Arch Gen Psychiatry. 1997;54(8):700-705.


Abstract

Background
The selective serotonergic medication fluoxetine has demonstrated efficacy in the treatment of major depression and has suggested efficacy in the treatment of alcoholism. However, no completed trials with any selective serotonergic medication have been reported in patients who display both major depression and alcoholism, despite previous observations that both depression and alcoholism are associated with low serotonergic functioning.

Methods
Fifty-one patients diagnosed as having comorbid major depressive disorder and alcohol dependence were randomized to receive fluoxetine (n=25) or placebo (n=26) in a 12-week, double-blind, parallel-group trial. Weekly ratings of depression and alcohol consumption were obtained throughout the 12-week course of the study.

Results
The improvement in depressive symptoms during the medication trial was significantly greater in the fluoxetine group than in the placebo group. Total alcohol consumption during the trial was significantly lower in the fluoxetine group than in the placebo group.

Conclusions
Fluoxetine is effective in reducing the depressive symptoms and the alcohol consumption of patients with comorbid major depressive disorder and alcohol dependence. It is unknown whether these results generalize to the treatment of less depressed and less suicidal alcoholics.



Author Affiliations

From the Department of Psychiatry, Western Psychiatric Institute and Clinic, Pittsburgh, Pa.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The alcohol withdrawal syndrome
McKeon et al.
J. Neurol. Neurosurg. Psychiatry 2008;79:854-862.
ABSTRACT | FULL TEXT  

Unhealthy Alcohol Use
Saitz
NEJM 2005;352:596-607.
FULL TEXT  

Efficacy of Valproate Maintenance in Patients With Bipolar Disorder and Alcoholism: A Double-blind Placebo-Controlled Study
Salloum et al.
Arch Gen Psychiatry 2005;62:37-45.
ABSTRACT | FULL TEXT  

Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology
Lingford-Hughes et al.
J Psychopharmacol 2004;18:293-335.
 

Dual diagnosis: management within a psychosocial context
Abou-Saleh
Adv. Psychiatr. Treat. 2004;10:352-360.
ABSTRACT | FULL TEXT  

Drug treatment for personality disorders
Tyrer and Bateman
Adv. Psychiatr. Treat. 2004;10:389-398.
ABSTRACT | FULL TEXT  

Treatment of Depression in Patients With Alcohol or Other Drug Dependence: A Meta-analysis
Nunes and Levin
JAMA 2004;291:1887-1896.
ABSTRACT | FULL TEXT  

Mirtazapine Improves Alcohol Detoxification
Liappas et al.
J Psychopharmacol 2004;18:88-93.
ABSTRACT  

SERTRALINE FOR THE PREVENTION OF RELAPSE IN DETOXICATED ALCOHOL DEPENDENT PATIENTS WITH A COMORBID DEPRESSIVE DISORDER: A RANDOMIZED CONTROLLED TRIAL
Gual et al.
Alcohol Alcohol 2003;38:619-625.
ABSTRACT | FULL TEXT  

Management of Drug and Alcohol Withdrawal
Kosten and O'Connor
NEJM 2003;348:1786-1795.
FULL TEXT  

Suicides in persons suffering from rheumatoid arthritis
Timonen et al.
Rheumatology (Oxford) 2003;42:287-291.
ABSTRACT | FULL TEXT  

Major Depression in 6050 Former Drinkers: Association With Past Alcohol Dependence
Hasin and Grant
Arch Gen Psychiatry 2002;59:794-800.
ABSTRACT | FULL TEXT  

Effects of Major Depression on Remission and Relapse of Substance Dependence
Hasin et al.
Arch Gen Psychiatry 2002;59:375-380.
ABSTRACT | FULL TEXT  

Treating depression complicated by substance misuse
McIntosh and Ritson
Adv. Psychiatr. Treat. 2001;7:357-364.
FULL TEXT  

The Patient Recovering from Alcohol or Drug Addiction: Special Issues for the Anesthesiologist
May et al.
Anesth. Analg. 2001;92:1601-1608.
FULL TEXT  

Drug Therapy for Alcohol Dependence
Swift
NEJM 1999;340:1482-1490.
FULL TEXT  

Do antidepressants have any potential to cause addiction?
Haddad
J Psychopharmacol 1999;13:300-307.
ABSTRACT  

Pharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt et al.
JAMA 1999;281:1318-1325.
ABSTRACT | FULL TEXT  

Fluoxetine reduced depressive symptoms and alcohol consumption in patients with comorbid major depression and alcohol dependence
Haslam
Evid. Based Ment. Health 1998;1:41-41.
FULL TEXT  

Fluoxetine for Depressed Alcoholics
JWatch Psychiatry 1997;1997:6-6.
FULL TEXT  

FLUOXETINE FOR DEPRESSED ALCOHOLICS
JWatch General 1997;1997:2-2.
FULL TEXT  

Drug Abuse and Addiction Treatment Research: The Next Generation
Leshner
Arch Gen Psychiatry 1997;54:691-694.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.